Logos Global Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Logos Global Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-410,000	Closed	-$11.7M	–	60
2023 Q1	$11.7M	Sell	410,000 -250,000	-38%	-$7.4M	1.68%	25
2022 Q4	$20.6M	Sell	660,000 -425,251	-39%	-$13.9M	2.41%	19
2022 Q3	$22M	Buy	1,085,251 +100,000	+10%	+$1.82M	2.71%	15
2022 Q2	$15.3M	Sell	985,251 -400,000	-29%	-$6.88M	2.81%	14
2022 Q1	$26.5M	Sell	1,385,251 -279,000	-17%	-$4.98M	3.44%	15
2021 Q4	$42.1M	Buy	1,664,251 +504,000	+43%	+$14.8M	4.34%	6
2021 Q3	$38M	Buy	+1,160,251	New	+$39.5M	2.74%	13

Other funds holding DICE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Logos Global Management's DICE Position: Q2 2023 in Review

Logos Global Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q2 2023, closing a stake of 410,000 shares — an estimated $11.7M sold.

Logos Global Management first reported a position in DICE in Q3 2021 and held it in 7 quarters. The position peaked at $42.1M in Q4 2021. 160 funds tracked by Wall St. Rank hold DICE as of Q2 2023.

Logos Global Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Logos Global Management sold 410,000 DICE Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $11.7M.
Logos Global Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
Logos Global Management's DICE Therapeutics, Inc. Common Stock position peaked at $42.1M in Q4 2021.
160 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Logos Global Management's 13F filing for Q2 2023, filed 14 Aug 2023.